YARROW BIOSCIENCE, INC. Write off of Deferred Debt Issuance Cost
YARROW BIOSCIENCE, INC. (YARW) reported Write off of Deferred Debt Issuance Cost of $1.60 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:WriteOffOfDeferredDebtIssuanceCost · last filed 2023-03-14
- YARROW BIOSCIENCE, INC. write off of deferred debt issuance cost for the quarter ending 2021-12-31 was $0.00.
- YARROW BIOSCIENCE, INC. write off of deferred debt issuance cost for the quarter ending 2021-09-30 was $1.60M.
- YARROW BIOSCIENCE, INC. write off of deferred debt issuance cost for fiscal 2021 was $1.60M.
| Period end | Write off of Deferred Debt Issuance Cost 3 month | Write off of Deferred Debt Issuance Cost 6 month | Write off of Deferred Debt Issuance Cost 9 month | Write off of Deferred Debt Issuance Cost 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $1.60M derived: sum of 2 quarters · filed 2023-03-14 | $1.60M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $1.60M 10-Q · filed 2021-11-10 | $1.60M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |